A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group
- 12 August 1996
- journal article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 156 (15), 1729-1735
- https://doi.org/10.1001/archinte.156.15.1729